CGB's Israeli partners Pharmocann are getting into Mushrooms. Could CGB do an easy distribution deal on paper (Aust/NZ/Pacific/Japan/Korea?) with Pharmocann, it might be worth something to the share price, every little bit helps. I think Pharmocann own 50% of Fusspot dont they?
Pharmocann teams with Shamir Institute on magic mushrooms